|
| 36272581 | From thymus to tissues and tumors: AÂ review of T-cell biology. | J Allergy Clin Immunol | 2023 |
| 36272581 | From thymus to tissues and tumors: AÂ review of T-cell biology. | J Allergy Clin Immunol | 2023 |
| 37559725 | T cell intrinsic STAT1 signaling prevents aberrant Th1 responses during acute toxoplasmosis. | Front Immunol | 2023 |
| 37552767 | TGF-β uncouples glycolysis and inflammation in macrophages and controls survival during sepsis. | Sci Signal | 2023 |
| 37957354 | Microbial ligand-independent regulation of lymphopoiesis by NOD1. | Nat Immunol | 2023 |
| 36948491 | Biologic Versus Small Molecule Therapy for Treating Moderate to Severe Atopic Dermatitis: Clinical Considerations. | J Allergy Clin Immunol Pract | 2023 |
| 37256972 | Variant <i>STAT4</i> and Response to Ruxolitinib in an Autoinflammatory Syndrome. | N Engl J Med | 2023 |
| 37443284 | Transcription factor EGR2 controls homing and pathogenicity of T<sub>H</sub>17 cells in the central nervous system. | Nat Immunol | 2023 |
| 37188939 | Protein kinases: drug targets for immunological disorders. | Nat Rev Immunol | 2023 |
| 37540600 | Transcription factor TCF-1 regulates the functions, but not the development, of lymphoid tissue inducer subsets in different tissues. | Cell Rep | 2023 |
| 37559725 | T cell intrinsic STAT1 signaling prevents aberrant Th1 responses during acute toxoplasmosis. | Front Immunol | 2023 |
| 37957354 | Microbial ligand-independent regulation of lymphopoiesis by NOD1. | Nat Immunol | 2023 |
| 37552767 | TGF-β uncouples glycolysis and inflammation in macrophages and controls survival during sepsis. | Sci Signal | 2023 |
| 37540600 | Transcription factor TCF-1 regulates the functions, but not the development, of lymphoid tissue inducer subsets in different tissues. | Cell Rep | 2023 |
| 37256972 | Variant <i>STAT4</i> and Response to Ruxolitinib in an Autoinflammatory Syndrome. | N Engl J Med | 2023 |
| 37188939 | Protein kinases: drug targets for immunological disorders. | Nat Rev Immunol | 2023 |
| 36948491 | Biologic Versus Small Molecule Therapy for Treating Moderate to Severe Atopic Dermatitis: Clinical Considerations. | J Allergy Clin Immunol Pract | 2023 |
| 37443284 | Transcription factor EGR2 controls homing and pathogenicity of T<sub>H</sub>17 cells in the central nervous system. | Nat Immunol | 2023 |
| 34001528 | Evolving Views of Long Noncoding RNAs and Epigenomic Control of Lymphocyte State and Memory. | Cold Spring Harb Perspect Biol | 2022 |
| 36240739 | The JAK-STAT pathway at 30: Much learned, much more to do. | Cell | 2022 |
| 36427325 | A central role for STAT5 in the transcriptional programing of T helper cell metabolism. | Sci Immunol | 2022 |
| 34001528 | Evolving Views of Long Noncoding RNAs and Epigenomic Control of Lymphocyte State and Memory. | Cold Spring Harb Perspect Biol | 2022 |
| 34987201 | Janus kinase-targeting therapies in rheumatology: a mechanisms-based approach. | Nat Rev Rheumatol | 2022 |
| 36427325 | A central role for STAT5 in the transcriptional programing of T helper cell metabolism. | Sci Immunol | 2022 |
| 36240739 | The JAK-STAT pathway at 30: Much learned, much more to do. | Cell | 2022 |
| 34987201 | Janus kinase-targeting therapies in rheumatology: a mechanisms-based approach. | Nat Rev Rheumatol | 2022 |
| 33237303 | Compromised counterselection by FAS creates an aggressive subtype of germinal center lymphoma. | J Exp Med | 2021 |
| 34180156 | A Decade of JAK Inhibitors: What Have We Learned and What May Be the Future? | Arthritis Rheumatol | 2021 |
| 33841440 | Multi-Dimensional Gene Regulation in Innate and Adaptive Lymphocytes: A View From Regulomes. | Front Immunol | 2021 |
| 33574619 | BACH2 enforces the transcriptional and epigenetic programs of stem-like CD8<sup>+</sup> T cells. | Nat Immunol | 2021 |
| 34099646 | Phase 1 double-blind randomized safety trial of the Janus kinase inhibitor tofacitinib in systemic lupus erythematosus. | Nat Commun | 2021 |
| 33939926 | Immunology Lessons from the SARS-CoV-2 Pandemic. | Annu Rev Immunol | 2021 |
| 33658708 | Author Correction: BACH2 enforces the transcriptional and epigenetic programs of stem-like CD8<sup>+</sup> T cells. | Nat Immunol | 2021 |
| 33657395 | MicroRNA-221 and -222 modulate intestinal inflammatory Th17 cell response as negative feedback regulators downstream of interleukin-23. | Immunity | 2021 |
| 33930196 | JAK inhibitors: Ten years after. | Eur J Immunol | 2021 |
| 34301840 | Cutting Edge: Steroid Responsiveness in Foxp3<sup>+</sup> Regulatory T Cells Determines Steroid Sensitivity during Allergic Airway Inflammation in Mice. | J Immunol | 2021 |
| 33237303 | Compromised counterselection by FAS creates an aggressive subtype of germinal center lymphoma. | J Exp Med | 2021 |
| 34625141 | JAK-STAT signaling in human disease: From genetic syndromes to clinical inhibition. | J Allergy Clin Immunol | 2021 |
| 34623903 | Cholesterol 25-hydroxylase is a metabolic switch to constrain T cell-mediated inflammation in the skin. | Sci Immunol | 2021 |
| 34644563 | PI3Kδ coordinates transcriptional, chromatin, and metabolic changes to promote effector CD8<sup>+</sup> T cells at the expense of central memory. | Cell Rep | 2021 |
| 34586363 | MicroRNA-directed pathway discovery elucidates an miR-221/222-mediated regulatory circuit in class switch recombination. | J Exp Med | 2021 |
| 35056105 | Jakinibs of All Trades: Inhibiting Cytokine Signaling in Immune-Mediated Pathologies. | Pharmaceuticals (Basel) | 2021 |
| 33574619 | BACH2 enforces the transcriptional and epigenetic programs of stem-like CD8<sup>+</sup> T cells. | Nat Immunol | 2021 |
| 33841440 | Multi-Dimensional Gene Regulation in Innate and Adaptive Lymphocytes: A View From Regulomes. | Front Immunol | 2021 |
| 33930196 | JAK inhibitors: Ten years after. | Eur J Immunol | 2021 |
| 33658708 | Author Correction: BACH2 enforces the transcriptional and epigenetic programs of stem-like CD8<sup>+</sup> T cells. | Nat Immunol | 2021 |
| 33657395 | MicroRNA-221 and -222 modulate intestinal inflammatory Th17 cell response as negative feedback regulators downstream of interleukin-23. | Immunity | 2021 |
| 35056105 | Jakinibs of All Trades: Inhibiting Cytokine Signaling in Immune-Mediated Pathologies. | Pharmaceuticals (Basel) | 2021 |
| 34644563 | PI3Kδ coordinates transcriptional, chromatin, and metabolic changes to promote effector CD8<sup>+</sup> T cells at the expense of central memory. | Cell Rep | 2021 |
| 34586363 | MicroRNA-directed pathway discovery elucidates an miR-221/222-mediated regulatory circuit in class switch recombination. | J Exp Med | 2021 |